Sio Capital Management, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001482416
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 54 positions · Total reported value $506.72M · Top-10 concentration 47.9% · Updated 2026-11-16
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
Turnover: 61.6% · 14 new · 12 cut · 19 exited
Active Share (vs S&P 500): 99.1% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -6.4% · vs SPY -8.6% · Prev Value $604.29M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -1.5% · vs SPY -3.6% · Latest Value $506.72M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2026 13F filing, Sio Capital Management, LLC disclosed 54 equity positions with a combined reported value of $506.72M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.9% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were AVR ($40.24M), GMED ($35.66M), GSK ($32.33M). By sector, the heaviest allocations are Health Care 95.9%, Consumer Discretionary 2.8%. Versus the prior quarter, allocation shifted toward Health Care (+9.3pp), Financials (+1.0pp) and away from Industrials (-1.2pp), Other (-2.4pp).
Versus the prior quarter, Sio Capital Management, LLC opened 14 new positions, trimmed 12 and fully exited 19, a turnover rate of 61.6% of positions. The portfolio's overlap with the prior quarter was 55% of names.
The largest new positions opened in Q3 2026 were MRK ($21.14M), PFE ($17.11M), REPL ($11.46M).
Of the 19 positions fully exited versus the prior quarter, the largest were COR ($49.12M), TYRA ($22.21M), WAY ($19.01M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
Fully Exited (vs previous quarter)
- COR CENCORA INC · prev qtr: $49.12M
- TYRA TYRA BIOSCIENCES INC · prev qtr: $22.21M
- WAY WAYSTAR HLDG CORP · prev qtr: $19.01M
- ORKA ORUKA THERAPEUTICS INC · prev qtr: $16.86M
- CCRN CROSS CTRY HEALTHCARE INC · prev qtr: $14.51M
- ABT ABBOTT LABORATORIES · prev qtr: $11.67M
- ZBH ZIMMER BIOMET HOLDINGS INC · prev qtr: $11.32M
- REGN REGENERON PHARMACEUTICALS · prev qtr: $11.22M
Insider Transactions (Form 4)
Latest Sio Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Sio Capital Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 59 positions worth $604.29M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-78021 (status: Approved), registered 2013-05-16
- Regulatory AUM (Form ADV): $1.29B as of 2026-03-18
- Client mix (by RAUM): pension and profit-sharing plans 53%, pooled investment vehicles 47%
- Manages 2 private funds, of which 2 hedge funds
- Website: siocapital.com
Portfolio Structure
- 59 positions · $604.29M reported value (Q2 2026)
- Top 10 holdings = 48.6% of reported value
- Largest position: AVR (ANTERIS TECHNOLOGIES GLOBAL COM) at 9.0%
- Average position size: $10.24M
Sector Tilt
- Health Care 86.6%
- Consumer Discretionary 6.4%
- Information Technology 3.1%
- (classified holdings cover 98% of value)
Quarterly Activity
- Q2 2026: 16 new, 10 added, 22 reduced, 33 exited
- 11 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
5.18M | $40.24M | 7.94% | Reduce | |
| 2 |
|
476.11K | $35.66M | 7.04% | Add | |
| 3 |
|
671.12K | $32.33M | 6.38% | Add | |
| 4 |
|
141.00K | $23.97M | 4.73% | Add | |
| 5 |
|
2.29M | $23.30M | 4.60% | Add | |
| 6 |
|
145.49K | $21.14M | 4.17% | New | |
| 7 |
|
500.12K | $19.21M | 3.79% | Add | |
| 8 |
|
600.00K | $17.11M | 3.38% | New | |
| 9 |
|
1.23M | $15.15M | 2.99% | Hold | |
| 10 |
|
356.18K | $14.69M | 2.90% | Reduce | |
| 11 |
|
9.10M | $14.57M | 2.88% | Reduce | |
| 12 |
|
268.28K | $14.27M | 2.82% | Reduce | |
| 13 |
|
3.63M | $13.68M | 2.70% | Add | |
| 14 |
|
755.49K | $13.39M | 2.64% | Reduce | |
| 15 |
|
1.01M | $12.56M | 2.48% | Add | |
| 16 |
|
865.33K | $11.46M | 2.26% | New | |
| 17 |
|
428.86K | $10.70M | 2.11% | Add | |
| 18 |
|
146.27K | $10.63M | 2.10% | Add | |
| 19 |
|
174.31K | $10.46M | 2.06% | New | |
| 20 |
|
126.34K | $10.05M | 1.98% | Add | |
| 21 |
|
61.85K | $9.99M | 1.97% | New | |
| 22 |
|
291.23K | $9.79M | 1.93% | Reduce | |
| 23 |
|
873.38K | $9.76M | 1.93% | Reduce | |
| 24 |
|
33.94K | $9.22M | 1.82% | Reduce | |
| 25 |
|
158.05K | $8.93M | 1.76% | New | |
| 26 |
|
282.00K | $8.53M | 1.68% | New | |
| 27 |
|
561.29K | $6.90M | 1.36% | Reduce | |
| 28 |
|
1.99M | $6.07M | 1.20% | Add | |
| 29 |
|
3.63M | $6.07M | 1.20% | Add | |
| 30 |
|
1.28M | $5.92M | 1.17% | Reduce | |
| 31 |
|
82.90K | $5.37M | 1.06% | New | |
| 32 |
|
766.36K | $5.23M | 1.03% | New | |
| 33 |
|
500.00K | $5.10M | 1.01% | New | |
| 34 |
|
44.70K | $4.71M | 0.93% | New | |
| 35 |
|
529.15K | $4.38M | 0.86% | New | |
| 36 |
|
2.00M | $4.00M | 0.79% | Add | |
| 37 |
|
75.15K | $3.74M | 0.74% | Add | |
| 38 |
|
657.10K | $3.39M | 0.67% | Add | |
| 39 |
|
1.08M | $2.95M | 0.58% | Hold | |
| 40 |
|
548.10K | $2.92M | 0.57% | Add | |
| 41 |
|
132.10K | $2.84M | 0.56% | Add | |
| 42 |
|
95.46K | $2.57M | 0.51% | Reduce | |
| 43 |
|
1.01M | $2.50M | 0.49% | Hold | |
| 44 |
|
327.24K | $1.84M | 0.36% | Hold | |
| 45 |
|
481.60K | $1.78M | 0.35% | New | |
| 46 |
|
184.42K | $1.50M | 0.30% | New | |
| 47 |
|
152.46K | $1.38M | 0.27% | Hold | |
| 48 |
|
373.67K | $1.22M | 0.24% | Reduce | |
| 49 |
|
440.45K | $1.12M | 0.22% | Add | |
| 50 |
|
904.27K | $1.07M | 0.21% | Hold | |
FAQ
What did Sio Capital Management, LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, Sio Capital Management, LLC reported 54 equity positions worth $506.72M in aggregate; its largest disclosed positions were AVR ($40.24M), GMED ($35.66M), GSK ($32.33M).
How large is Sio Capital Management, LLC's portfolio?
Sio Capital Management, LLC reported $506.72M of long equity holdings across 54 positions as of 2026-Q3. Top-10 holdings account for 47.9% of reported value.
What is Sio Capital Management, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.